Global high content screening market is anticipated to exhibit lucrative market growth owing to increasing prevalence of chronic diseases such as HIV AIDS, increasing need of determination and study of toxicity in the initial stages of drug discovery. Technological advancements which include incorporation of multicolored fluorescence based reagents and polarization techniques are expected to boost the market growth further. This result in increased stability of new drugs and reduction in drug discovery time hence is expected to further boost the demand for the market.
Browse full research report on Global High Content Screening Market: http://www.grandviewresearch.com/industry-analysis/high-content-screening-market

The global high content screening market is segregated on the basis of end use, product and application. On the basis of product, it is segmented into instruments, consumables, microplates, software and service. On the basis of application, it is divided into target identification & validation; compound profiling, primary & secondary screening. Under end-use segment, there are contract research organizations, academic & research institutes and pharmaceutical & biotechnology companies As of 2014, the high screening instrument segment held the substantial share in high content screening market owing to need for high cost efficient alternatives and technological advancements. High content screening software segment is expected to grow at a lucrative rate over the forecast period owing to features like intuitive workflow interface and confocal imaging.
Request For TOC of this report: http://www.grandviewresearch.com/industry-analysis/high-content-screening-market/request-toc

As of 2014, North America held the largest share of the high content screening market owing to various growth factors which includes increasing prevalence of geriatric population and rising incidences of chronic diseases and advanced healthcare infrastructure. Asia Pacific is expected to be the fastest growing owing to rising need of novel drugs, improving healthcare infrastructure and rising number of new market players are anticipated to play a significant role in growth of high content screening market in this region over the forecast period.

Access More reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it
Major players of high content screening market are PerkinElmer Inc., Becton, Dickinson and Company, GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Thorlabs, Inc., Genedata AG, Molecular Devices, and Yokogawa Electric Corporation. These companies aim mergers & acquisitions and developing advanced technologies and in order to dominate the high content screening market. For instance, Thermo Fisher Scientific launched New CeLLInsight CX5 high content screening platform for quantitative cell-based imaging which is enabled with true five-color spectral illumination providing access wider range of fluorescent.



About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

For more information, visit: http://www.grandviewresearch.com/

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Read our blogs - www.divog.org, www.terrapass.org, www.apavirginia.org